• Accueil >
  • Publications >
  • Our experience of solitary plasmacytoma of the bone: improved PFS with a short-course treatment by IMiDs or proteasome inhibitors combined with intensity-modulated radiotherapy

Our experience of solitary plasmacytoma of the bone: improved PFS with a short-course treatment by IMiDs or proteasome inhibitors combined with intensity-modulated radiotherapy

3 juil. 2018Leukemia & Lymphoma

DOI : 10.1080/10428194.2017.1393667

Auteurs

Emmanuelle Le Ray, Lisa Belin, Corine Plancher, Philippe Anract, Antoine Babinet, Valérie Dumaine, Jérôme Tamburini, Bénédicte Deau Fischer, Lise Willems, Leonardo Magro, Thierry Facon, Xavier Leleu, Didier Bouscary, Youlia M. Kirova